Synthesis method for preparing PARP inhibitor Niraparib

A synthesis method and an inhibitor technology, which are applied in the field of synthesis of the PARP inhibitor Niraparib, can solve problems such as difficulty in realizing large-scale industrial production, restrictions on industrial safety production, and long synthesis routes, and achieve easy large-scale production and industrialization The effect of large production and short synthetic route

Inactive Publication Date: 2017-03-15
SHAANXI UNIV OF SCI & TECH
View PDF0 Cites 20 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

The synthetic route is relatively long, and Niraparib obtained by using Chiralpak AS-H normal phase chiral chromatographic column is not easy to achieve large-scale indu

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Synthesis method for preparing PARP inhibitor Niraparib
  • Synthesis method for preparing PARP inhibitor Niraparib
  • Synthesis method for preparing PARP inhibitor Niraparib

Examples

Experimental program
Comparison scheme
Effect test

Embodiment

[0034] Intermediate (II) The synthesis of intermediate (II) is divided into two steps, the preparation of the first step diazonium salt: 52mL (0.4mol) methyl anthranilate is mixed with 170mL 20% sulfuric acid (0.62mol), cooled to At 10°C, slowly add 42 mL of 30% sodium nitrite (0.4 mol) solution dropwise into the reaction flask. Check the excess nitrous acid with starch potassium iodide test paper to determine the end point of the reaction. The generated brown-red diazonium salt carries out the coupling reaction of the second step with tert-butyl-3-phenylpiperidine-1-carboxylate: get 100g (0.4mol) tert-butyl-3-phenylpiperidine- 1-tert-butyl formate was dissolved in 500mL of 10% sodium hydroxide solution, and was dripped into the above-mentioned diazonium salt under constant stirring, stirred for 5h, left to stand for crystallization, suction filtered, and recrystallized in ethanol to obtain 127g of the intermediate (II ), yield: 78%.

[0035] 1 H-NMR (400MHz, DMSO-d6) (pp...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention provides a novel synthesis method for preparing a PARP inhibitor Niraparib. The method comprises the steps that a starting material methyl anthranilate is subjected to diazo coupling, cyclization, amidation, BOC removal and chiral resolution, and then the Niraparib with the purity reaching 99.5% is obtained. The method is simple, convenient and easy to operate suitable for industrial production.

Description

technical field [0001] The invention belongs to the technical field of drug synthesis, and relates to a synthesis method for preparing PARP inhibitor Niraparib. Background technique [0002] Niraparib is an oral poly ADP-ribose polymerase (PARP) inhibitor, which can inhibit the repair of DNA damage in cells and is suitable for cancers with BRCA1 / 2 gene mutations, such as ovarian cancer and breast cancer, developed by Tesaro, an American biotechnology company. research and development. For cancer cells with BRCA gene mutations, if PARP activity is further inhibited, these cells will generate a lot of DNA damage when they divide, leading to the death of cancer cells. The chemical name of Niraparib is 2-[4-((3S)-3-piperidinyl)phenyl]-2H-indazole-7-carboxamide, and a phase III clinical trial called NOVA has been completed. Niraparib shows very good curative effect. In the trial, the researchers recruited more than 500 patients with ovarian cancer recurrence after platinum-bas...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): C07D401/10
CPCY02P20/55C07D401/10
Inventor 梁承远贾敏一田丹妮孙涵丁顺军田蕾
Owner SHAANXI UNIV OF SCI & TECH
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap